OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares
$5.66
价格 · 八月 19, 2026
截至...的财报数据 八月 10, 2026
52周区间
$2–$6
97% of range
分析师评级
BUY
13 analysts
目标价
$12
+118% upside
P/E (TTM)
-5.1
ROE
-195.7%
净利润率
-157.4%
OBIO 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$5.66
市值
$323M
P/E (TTM)
-5.1
每股收益 (TTM)
$-1.11
营收 (TTM)
$33M
股息收益率
—
ROE
-195.7%
负债/权益
—
52周区间
$2 – $6
OBIO 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$33M
2022-12-31
→
2025-12-31
EPS
$-1.11
2021-12-31
→
2025-12-31
自由现金流
$-49M
2023-12-31
→
2025-12-31
利润率
-157.4%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
OBIO
同行中位数
P/E (TTM)
-5.1
27.5
P/S (TTM) (市销率 (TTM))
9.6
6.8
P/B (市净率)
6.0
3.7
Price / FCF (股价/自由现金流)
-6.5
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
OBIO
同行中位数
Operating Margin (营业利润率)
-154.7%
—
Net Profit Margin (净利润率)
-157.4%
-46.8%
ROA
-55.2%
-31.4%
ROE
-195.7%
-59.1%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
OBIO
同行中位数
Current Ratio (流动比率)
6.4
4.6
Quick Ratio (速动比率)
6.4
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
OBIO
同行中位数
Revenue YoY (营收同比增长)
1169.2%
—
Revenue CAGR 3Y (营收3年复合年增长率)
111.6%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
OBIO
同行中位数
OBIO 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
13 位分析师
- 强烈买入 3 23.1%
- 买入 8 61.5%
- 持有 2 15.4%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
6 位分析师 · 2026-08-15
中位数
$10.00
平均值
$12.33
← 低于所有目标
$5.66
最低
$9.00
最高
$20.00
中位数目标
$10.00
+76.8%
平均目标
$12.33
+118.1%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.07%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.38 | $-0.40 | 0.02% |
| 2026年3月31日 | $-0.33 | $-0.44 | 0.11% |
| 2025年12月31日 | $-0.13 | $-0.39 | 0.26% |
| 2025年9月30日 | $-0.40 | $-0.44 | 0.04% |
| 2025年6月30日 | $-0.50 | $-0.51 | 0.01% |
| 2025年3月31日 | $-0.49 | $-0.49 | 0.00% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| OBIO | $237M | -3.7 | 1169.2% | -157.4% | -195.7% | — |
| SI | $295M | -3.1 | 49.6% | -85.3% | -129.1% | 76.5% |
| OFIX | $604M | -6.5 | 2.9% | -11.2% | -20.3% | 68.8% |
| CARL | $329M | -5.8 | 85.9% | -58.7% | -375.2% | 75.3% |
| MOBI | — | — | — | — | — | — |
| CV | $501M | -10.4 | 15.3% | -186.8% | 40.3% | 52.9% |
| TMCI | — | -2.6 | 1.6% | -27.7% | -63.8% | 79.8% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $33M | $3M | $3M | $4M | |
| Cost of Revenue | $190.0K | $204.0K | $186.0K | $211.0K | |
| R&D Expense | $58M | $43M | $34M | $22M | |
| SG&A Expense | $27M | $24M | $20M | $14M | |
| Operating Expenses | $85M | $67M | $54M | $36M | |
| Operating Income | $-52M | $-64M | $-52M | $-33M | |
| Interest Income | · | · | · | $345.1K | |
| Other Non-op | · | $-11.0K | · | · | |
| Income Tax | $0 | · | · | · | |
| Net Income | $-53M | $-61M | $-49M | $-34M | |
| EPS (Basic) | $-1.11 | $-1.66 | $-1.48 | $-2.24 | |
| EPS (Diluted) | $-1.11 | $-1.66 | $-1.48 | $-2.24 | |
| Shares (Basic) | 47,747,078 | 36,821,042 | 33,225,227 | 14,988,584 | |
| Shares (Diluted) | 47,747,078 | 36,821,042 | 33,225,227 | 14,988,584 | |
| EBITDA | $-51M | $-64M | $-51M | $-3M |
资产负债表 25
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $35M | $22M | $31M | $20M | |
| Short-term Investments | $72M | $45M | $57M | $64M | |
| Receivables | $95.0K | $92.0K | $99.0K | $96.0K | |
| Inventory | $310.0K | $173.0K | $146.0K | $276.0K | |
| Prepaid Expense | $994.0K | $2M | $1M | $533.0K | |
| Current Assets | $108M | $69M | $89M | $85M | |
| PP&E (Net) | $2M | $1M | $1M | $1M | |
| PP&E (Gross) | $3M | $3M | $2M | $2M | |
| Accum. Depreciation | $2M | $1M | $1M | $778.0K | |
| Total Assets | $115M | $76M | $95M | $96M | |
| Accounts Payable | $6M | $5M | $3M | $4M | |
| Accrued Liabilities | $10M | $6M | $5M | $5M | |
| Current Liabilities | $17M | $16M | $11M | $19M | |
| Capital Leases | $936.0K | $2M | $1M | $2M | |
| Deferred Tax | $393.0K | $561.0K | $508.0K | $637.0K | |
| Other Non-current Liabilities | $308.0K | $40.0K | · | $196.0K | |
| Total Liabilities | $51M | $43M | $27M | $43M | |
| Long-term Debt | $15M | $15M | · | · | |
| Common Stock | $6.0K | $4.0K | $4.0K | $2.0K | |
| Paid-in Capital | $416M | $343M | $317M | $252M | |
| Retained Earnings | $-363M | $-310M | $-249M | $-200M | |
| AOCI | $60.0K | $52.0K | $-10.0K | $-8.0K | |
| Stockholders' Equity | $54M | $33M | $68M | $53M | |
| Liabilities + Equity | $115M | $76M | $95M | $96M | |
| Shares Outstanding | 57,032,963 | 38,194,442 | 35,777,412 | 20,187,850 |
现金流 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $327.0K | $308.0K | $287.0K | $222.0K | |
| Stock-based Comp | $12M | $11M | $8M | $3M | |
| Other Non-cash | $-9M | $-457.0K | $-5M | · | |
| Operating Cash Flow | $-49M | $-51M | $-46M | $-29M | |
| CapEx | $489.0K | $289.0K | $78.0K | $591.0K | |
| Investing Cash Flow | $-27M | $13M | $11M | $-64M | |
| Net Debt Issued | · | · | $-11M | · | |
| Financing Cash Flow | $88M | $29M | $46M | $103M | |
| Net Change in Cash | $12M | $-8M | $11M | $10M | |
| Free Cash Flow | $-49M | $-51M | $-46M | · |
盈利能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -154.7% | -2437.5% | -1866.2% | · | |
| Net Margin | -157.4% | -2313.3% | -1779.7% | · | |
| EBITDA Margin | -153.8% | -2425.8% | -1855.8% | · | |
| ROA | -55.2% | -71.2% | -51.5% | -2.4% | |
| ROE | -195.7% | -154.2% | -66.5% | -10.0% |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 6.4 | 4.3 | 8.0 | 0.2 | |
| Quick Ratio | 6.4 | 4.1 | 7.8 | 0.1 |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.0 | 0.0 | · | |
| Inventory Turnover | 0.8 | 1.3 | 0.9 | · | |
| Receivables Turnover | 358.1 | 27.6 | 28.3 | · |
增长率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 1169.2% | -4.4% | -21.9% | · | |
| Revenue CAGR 3Y | 111.6% | · | · | · |
估值 (TTM) 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $33M | $3M | $3M | $4M | |
| Net Income TTM | $-53M | $-61M | $-49M | $-34M | |
| Market Cap | $237M | $153M | $327M | $44M | |
| P/E | -3.7 | -2.4 | -6.2 | -4.5 | |
| P/S | 7.1 | 57.9 | 118.4 | 12.6 | |
| P/B | 4.4 | 4.6 | 4.8 | -6.4 | |
| P / Tangible Book | 4.4 | 4.6 | 4.8 | 0.8 | |
| P / Cash Flow | -4.8 | -3.0 | -7.1 | -28.1 | |
| P / FCF | -4.8 | -3.0 | -7.1 | · | |
| Earnings Yield | -26.8% | -41.5% | -16.2% | -22.4% |
损益表 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $88.0K | $110.0K | $31M | $861.0K | $836.0K | $868.0K | $253.0K | $987.0K | $778.0K | $620.0K | $262.0K | $419.0K | $915.0K | $1M | $1M | $1M | |
| Cost of Revenue | $25.0K | $32.0K | $51.0K | $49.0K | $46.0K | $44.0K | $58.0K | $68.0K | $44.0K | $34.0K | $47.0K | $41.0K | $54.0K | $44.0K | $53.0K | $56.0K | |
| R&D Expense | $17M | $16M | $17M | $14M | $14M | $13M | $11M | $12M | $11M | $9M | $9M | $9M | $8M | $8M | $8M | $6M | |
| SG&A Expense | $6M | $6M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $4M | $6M | $5M | $4M | $3M | $5M | |
| Operating Expenses | $22M | $22M | $24M | $21M | $20M | $20M | $17M | $17M | $18M | $15M | $13M | $15M | $14M | $13M | $11M | $11M | |
| Operating Income | $-22M | $-22M | $7M | $-20M | $-19M | $-19M | $-17M | $-16M | $-17M | $-14M | $-12M | $-15M | $-13M | $-12M | $-10M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | $351.0K | · | · | |
| Other Non-op | · | · | · | · | · | · | $0 | $0 | $0 | $-11.0K | · | · | · | · | · | · | |
| Net Income | $-24M | $-21M | $6M | $-21M | $-19M | $-19M | $-16M | $-15M | $-16M | $-13M | $-13M | $-13M | $-12M | $-11M | $-10M | $-10M | |
| EPS (Basic) | $-0.38 | $-0.33 | $0.28 | $-0.40 | $-0.50 | $-0.49 | $-0.42 | $-0.41 | $-0.45 | $-0.38 | $-0.35 | $-0.38 | $-0.35 | $-0.40 | $-0.34 | $-0.51 | |
| EPS (Diluted) | $-0.38 | $-0.33 | $0.28 | $-0.40 | $-0.50 | $-0.49 | $-0.42 | $-0.41 | $-0.45 | $-0.38 | $-0.35 | $-0.38 | $-0.35 | $-0.40 | $-0.34 | $-0.51 | |
| Shares (Basic) | 63,812,098 | 62,721,869 | -81,067,550 | 52,186,503 | 38,392,716 | 38,235,409 | -72,378,603 | 37,621,495 | 35,800,273 | 35,777,877 | -64,275,386 | 35,243,598 | 34,613,466 | 27,643,549 | -24,562,416 | 20,187,773 | |
| Shares (Diluted) | 63,812,098 | 62,721,869 | -81,067,550 | 52,186,503 | 38,392,716 | 38,235,409 | -72,378,603 | 37,621,495 | 35,800,273 | 35,777,877 | -64,275,386 | 35,243,598 | 34,613,466 | 27,643,549 | -24,562,416 | 20,187,773 | |
| EBITDA | $-22M | $-22M | · | $-20M | $-19M | $-19M | · | $-16M | $-17M | $-14M | · | $-15M | $-13M | $-11M | · | $-813.4K |
资产负债表 25
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $28M | $35M | $42M | $19M | $18M | $22M | $26M | $24M | $23M | $31M | $19M | $16M | $19M | $20M | $735.2K | |
| Short-term Investments | $89M | $66M | $72M | $54M | $15M | $32M | $45M | $41M | $41M | $52M | $57M | $89M | $101M | $108M | $64M | · | |
| Receivables | $51.0K | $84.0K | $95.0K | $52.0K | $83.0K | $89.0K | $92.0K | $115.0K | $80.0K | $67.0K | $99.0K | $86.0K | $171.0K | $76.0K | $96.0K | · | |
| Inventory | $250.0K | $277.0K | $310.0K | $365.0K | $185.0K | $135.0K | $173.0K | $234.0K | $70.0K | $115.0K | $146.0K | $137.0K | $178.0K | $232.0K | $276.0K | · | |
| Prepaid Expense | $977.0K | $1M | $994.0K | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $533.0K | $137.3K | |
| Current Assets | $111M | $96M | $108M | $98M | $36M | $52M | $69M | $69M | $66M | $76M | $89M | $110M | $120M | $130M | $85M | $872.6K | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | |
| PP&E (Gross) | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $993.0K | $921.0K | $849.0K | $778.0K | · | |
| Total Assets | $116M | $101M | $115M | $105M | $43M | $59M | $76M | $75M | $72M | $83M | $95M | $116M | $126M | $136M | $96M | $69M | |
| Accounts Payable | $6M | $6M | $6M | $8M | $5M | $6M | $5M | $5M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $281.6K | |
| Accrued Liabilities | $7M | $7M | $10M | $7M | $7M | $5M | $6M | $7M | $4M | $4M | $5M | $4M | $4M | $3M | $5M | $1M | |
| Current Liabilities | $13M | $14M | $17M | $21M | $17M | $15M | $16M | $16M | $15M | $10M | $11M | $21M | $12M | $12M | $19M | $1M | |
| Capital Leases | $520.0K | $730.0K | $936.0K | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | · | |
| Deferred Tax | · | · | $393.0K | · | · | · | $561.0K | · | · | · | $508.0K | · | · | · | $637.0K | · | |
| Other Non-current Liabilities | $397.0K | $367.0K | $308.0K | $248.0K | $189.0K | $99.0K | $40.0K | · | · | · | · | $266.0K | $213.0K | $249.0K | $196.0K | · | |
| Total Liabilities | $86M | $50M | $51M | $61M | $43M | $42M | $43M | $29M | $28M | $25M | $27M | $37M | $36M | $37M | $43M | $7M | |
| Long-term Debt | · | $15M | $15M | $15M | $15M | $15M | · | · | · | · | · | $10M | $10M | · | · | · | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $2.0K | $445 | |
| Paid-in Capital | $426M | $424M | $416M | $413M | $348M | $345M | $343M | $340M | $322M | $320M | $317M | $316M | $312M | $310M | $252M | · | |
| Retained Earnings | $-407M | $-383M | $-363M | $-369M | $-348M | $-329M | $-310M | $-294M | $-278M | $-262M | $-249M | $-236M | $-223M | $-211M | $-200M | $-6M | |
| AOCI | $-81.0K | $-40.0K | $60.0K | $45.0K | $16.0K | $37.0K | $52.0K | $98.0K | $-23.0K | $-8.0K | $-10.0K | $-77.0K | $-96.0K | $-35.0K | $-8.0K | · | |
| Stockholders' Equity | $19M | $41M | $54M | $44M | $295.0K | $17M | $33M | $46M | $44M | $57M | $68M | $80M | $89M | $100M | $53M | $-6M | |
| Liabilities + Equity | $116M | $101M | $115M | $105M | $43M | $59M | $76M | $75M | $72M | $83M | $95M | $116M | $126M | $136M | $96M | $69M | |
| Shares Outstanding | 60,105,049 | 58,630,715 | 57,032,963 | 56,464,731 | 38,643,553 | 38,312,512 | 38,194,442 | 37,942,905 | 35,824,571 | 35,784,997 | 35,777,412 | 35,743,972 | 35,743,007 | 31,741,147 | 20,187,850 | 4,450,000 |
现金流 9
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $96.0K | $90.0K | $82.0K | $81.0K | $81.0K | $83.0K | $84.0K | $76.0K | $74.0K | $74.0K | $72.0K | $71.0K | $73.0K | $71.0K | $70.0K | $54.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $919.0K | $4M | $2M | $1M | $863.0K | $2M | |
| Other Non-cash | · | $-4M | · | · | · | $-909.0K | · | · | · | $-2M | · | · | · | $-5M | · | · | |
| Operating Cash Flow | $-19M | $-22M | $-2M | $-15M | $-16M | $-17M | $-14M | $-14M | $-10M | $-13M | $-11M | $-10M | $-10M | $-14M | $-9M | $-20M | |
| CapEx | $254.0K | $184.0K | $33.0K | $310.0K | $34.0K | $112.0K | $106.0K | $68.0K | $107.0K | $8.0K | $-3.0K | $19.0K | $27.0K | $35.0K | $54.0K | $224.0K | |
| Investing Cash Flow | $-23M | $10M | $-18M | $-39M | $16M | $13M | $-4M | $557.0K | $10M | $6M | $33M | $13M | $8M | $-44M | $-63M | $-224.0K | |
| Financing Cash Flow | $35M | $6M | $13M | $76M | $-428.0K | $-296.0K | $14M | $15M | $171.0K | $18.0K | $-11M | $4.0K | $86.0K | $57M | $-5M | $-2M | |
| Net Change in Cash | $-8M | $-6M | $-7M | $23M | $401.0K | $-4M | $-3M | $2M | $389.0K | $-7M | $11M | $3M | $-2M | $-1M | $-77M | $88M | |
| Free Cash Flow | · | $-22M | · | · | · | $-17M | · | · | · | $-13M | · | · | · | $-14M | · | · |
盈利能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -25404.5% | -20069.1% | · | -2359.2% | -2311.8% | -2179.8% | · | -1655.7% | -2167.0% | -2326.3% | · | -3466.3% | -1416.0% | -991.8% | · | · | |
| Net Margin | -26994.3% | -18810.0% | · | -2419.1% | -2316.2% | -2160.7% | · | -1562.9% | -2054.0% | -2171.5% | · | -3178.0% | -1316.5% | -939.9% | · | · | |
| EBITDA Margin | -25404.5% | -19987.3% | · | -2359.2% | -2311.8% | -2170.3% | · | -1655.7% | -2167.0% | -2314.3% | · | -3466.3% | -1416.0% | -985.7% | · | · | |
| ROA | -30.0% | -25.9% | · | -23.1% | -33.6% | -26.5% | · | -16.1% | -16.1% | -12.3% | · | -14.4% | -8.4% | -7.3% | · | -0.59% | |
| ROE | -242.2% | -71.3% | · | -46.3% | -87.2% | -50.7% | · | -24.5% | -23.9% | -17.2% | · | -36.2% | -28.6% | -22.9% | · | 13.8% |
流动性与偿付能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.3 | 7.0 | · | 4.7 | 2.1 | 3.4 | · | 4.2 | 4.6 | 7.3 | · | 5.1 | 10.1 | 10.8 | · | 0.6 | |
| Quick Ratio | 8.2 | 6.9 | · | 4.6 | 2.0 | 3.2 | · | 4.1 | 4.5 | 7.2 | · | 5.1 | 9.9 | 10.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | -32.9 | · | · |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.1 | 0.2 | · | 0.2 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.2 | · | 0.6 | 0.6 | 0.4 | · | · | |
| Receivables Turnover | 1.3 | 1.3 | · | 10.3 | 10.3 | 11.1 | · | 9.8 | 6.2 | 8.7 | · | 9.7 | 10.7 | 30.6 | · | · |
估值 (TTM) 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $3M | · | $4M | $3M | $3M | · | $3M | $3M | $3M | · | $4M | $4M | $4M | · | · | |
| Net Income TTM | $-85M | $-80M | · | $-74M | $-70M | $-64M | · | $-58M | $-55M | $-50M | · | $-47M | $-41M | $-35M | · | $-24M | |
| Market Cap | $259M | $249M | · | $140M | $104M | $164M | · | $195M | $292M | $189M | · | $312M | $250M | $621M | · | $44M | |
| P/E | -2.7 | -2.5 | · | -1.4 | -1.4 | -2.5 | · | -3.2 | -5.2 | -3.5 | · | -5.3 | -3.4 | -8.5 | · | -5.2 | |
| P/S | 136.9 | 93.2 | · | 39.4 | 29.9 | 50.4 | · | 69.6 | 106.9 | 60.5 | · | 85.1 | 68.7 | 172.8 | · | · | |
| P/B | 13.4 | 6.0 | · | 3.2 | 351.1 | 9.7 | · | 4.2 | 6.6 | 3.3 | · | 3.9 | 2.8 | 6.2 | · | -7.3 | |
| P / Tangible Book | 13.4 | 6.0 | · | 3.2 | 351.1 | 9.7 | · | 4.2 | 6.6 | 3.3 | · | 3.9 | 2.8 | 6.2 | · | · | |
| P / Cash Flow | · | -11.2 | · | · | · | -9.9 | · | · | · | -14.4 | · | · | · | -43.2 | · | · | |
| P / FCF | · | -11.1 | · | · | · | -9.8 | · | · | · | -14.4 | · | · | · | -43.1 | · | · | |
| Earnings Yield | -37.3% | -40.5% | · | -72.6% | -69.0% | -40.4% | · | -31.5% | -19.1% | -28.6% | · | -18.8% | -29.0% | -11.8% | · | -19.2% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $33M | $3M | $3M | $4M | — |
| 营业利润率 % | -154.7% | -2437.5% | -1866.2% | — | — |
| 净收入 | $-53M | $-61M | $-49M | $-34M | $-378.8K |
| 稀释后每股收益 (EPS) | $-1.11 | $-1.66 | $-1.48 | $-2.24 | $-0.02 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 6.4 | 4.3 | 8.0 | 0.2 | 10.9 |
| 速动比率 | 6.4 | 4.1 | 7.8 | 0.1 | 10.6 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-49M | $-51M | $-46M | — | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 86 家申报者 · $108.0M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 29 (+10 与上一季度对比) | 13 (0 与上一季度对比) | 17 (-6 与上一季度对比) | 17 (+2 与上一季度对比) | +1.4M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 20 位内幕人士 · 11 位高管 · 7 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| David P Hochman | Chief Executive Officer and Chairperson | 2026年6月10日 F | 436199 | 5 | 0 | $116190 |
| Roderick Wong, M.D. | Chief Executive Officer | 2023年1月24日 P | 2808512 | 0 | 0 | $0 |
| Andrew Lawrence Taylor | Chief Financial Officer | 2026年6月10日 F | 593065 | 1 | 0 | $5100 |
| Michael Kaswan | Chief Financial Officer | 2023年1月26日 A | 162574 | 0 | 0 | $0 |
| Darren Sherman | President and Chief Operating Officer | 2026年8月3日 S | 1154327 | 1 | 3 | $-175590 |
| Joshua Aiello | Principal Accounting Officer | 2026年3月25日 F | 18644 | 0 | 0 | $0 |
| William Reed Little | Executive Vice President, Corporate Development & Strategy | 2024年5月30日 P | 307859 | 0 | 0 | $0 |
| George Papandreou | General Manager and Senior Vice President, Focal Therapies | 2024年5月8日 A | 42000 | 0 | 0 | $0 |
| Yuval Mika | General Manager and Chief Technology Officer, Bioelectronic Therapies | 2024年5月8日 A | 158905 | 0 | 0 | $0 |
| Stephanie A Sirota | VP of Corp Stratege and Comm | 2020年8月4日 P | 20000 | 0 | 0 | $0 |
| Alice Lee | VP Operations, Sec & Treasurer | 2020年8月4日 P | 10000 | 0 | 0 | $0 |
| Connealy Pamela Yanchik | 董事 | 2026年6月23日 A | 66038 | 0 | 0 | $0 |
| Jason Aryeh | 董事 | 2026年6月23日 A | 118118 | 3 | 0 | $39931 |
| Eric A Rose MD | 董事 | 2024年6月20日 A | 7544 | 0 | 0 | $0 |
| Geoffrey Wade Smith | 董事 | 2023年7月20日 A | 20913 | 0 | 0 | $0 |
| HSAC 2 Holdings, LLC | 10% 所有者 | 2024年8月5日 J | 1705705 | 0 | 0 | $0 |
| Chris Cleary | — | 2026年8月12日 F | 29153 | 0 | 0 | $0 |
| John Prosper Mack | — | 2026年8月12日 F | 66544 | 0 | 0 | $0 |
| David Pacitti | — | 2026年8月12日 F | 54750 | 0 | 0 | $0 |
| Eric S Fain | — | 2026年8月12日 F | 99630 | 2 | 0 | $97634 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 3 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| RTW Investments, LP, RTW Master Fund, Ltd., RTW Innovation Master Fund, Ltd., Roderick Wong ×8 申报 | 2026年4月29日 | 19.20% | 修订 | — | SEC |
| HSAC 2 Holdings, LLC ×3 申报 | 2024年8月7日 | — | 初始申报 | — | SEC |
| Geoffrey W. Smith | 2023年2月7日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 13 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| BIB · ProShares Trust | 0.01% | 2089 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.00% | 178322 NS | 2026年5月31日 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.00% | 3182 NS | 2026年5月31日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 43636 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| IWO · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWM · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWC · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | — | — | 2026年8月17日 | 每日 |